Use of principal component analysis and molecular docking to identify novel 
selective plasmepsin II inhibitors.

Valiente, P. A.; Wolf, M. G.; Guerra, Y.; Sierra, Y.; Wacker, S.; Pascual, I.; Pons, T.; Groenhof, G.

doi:10.1111/j.1742-4658.2010.08705.x

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Meeting Abstract

Use of principal component analysis and molecular docking to identify novel selective plasmepsin II inhibitors.

MPS-Authors

/persons/resource/persons41407

Wolf, M. G.
Department of Theoretical and Computational Biophysics, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15977

Wacker, S.
Research Group of Computational Biomolecular Dynamics, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15149

Groenhof, G.
Department of Theoretical and Computational Biophysics, MPI for biophysical chemistry, Max Planck Society;

External Resource

http://onlinelibrary.wiley.com/doi/10.1111/j.1742-4658.2010.08705.x/pdf
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Valiente, P. A., Wolf, M. G., Guerra, Y., Sierra, Y., Wacker, S., Pascual, I., et al. (2012). Use of principal component analysis and molecular docking to identify novel selective plasmepsin II inhibitors. FEBS Journal, 279(Supplement 1), 447-447. doi:10.1111/j.1742-4658.2010.08705.x.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000F-EFDC-8

Abstract

There is no abstract available